Vertex Pharmaceuticals is in the process of getting a new painkiller approved. It just published some data that suggests the candidate will be quite profitable. But regulators still need to sign ...

- First proteinuria data on povetacicept in primary membranous nephropathy shows mean UPCR reduction from baseline of 62% at 24 weeks – - Global Phase 3 RAINIER trial of povetacicept in IgA ...

But there was one company that kept at it. Fast-forward to today, and Vertex Pharmaceuticals is on the verge of gaining an FDA approval for suzetrigine (VX-548), a nonaddictive oral treatment that ...

Vertex has reported phase 3 data on its near-approval pain drug candidate suzetrigine, shedding light on how the non-opioid painkiller combines with ibuprofen and why the prospect failed to match ...

So when a business like Vertex Pharmaceuticals (NASDAQ: VRTX) releases some new data on a potential blockbuster that could be just a few months away from being approved for sale, it's a big ...

Facial recognition technology is revolutionizing how consumers shop, travel and purchase. It is used to better secure airport, hospital, retail store and entertainment venue entry points.

If you’ve ever glanced in the mirror and noticed your face has ballooned in size, it can be a bit of a jump scare. After all, facial swelling isn’t as common as, say, a twitchy eyelid.

There's nothing quite like the way your skin looks after a professional facial — glowy, firmer, perfectly hydrated, your pores smaller and unclogged. And while facials are typically considered ...

SOUTH BEND — The History Museum presents the program “Insights in History — A History of Facial Hair” at 1:30 p.m. Wednesday, Nov. 6 at 897 Thomas St. Registrar Catherine Page-Vanore ...